Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma

Abstract

An abstract is not available for this record. Please visit the publisher website for more details.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now